These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 18701571)

  • 1. Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis.
    Prakash RS; Snook EM; Lewis JM; Motl RW; Kramer AF
    Mult Scler; 2008 Nov; 14(9):1250-61. PubMed ID: 18701571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
    Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between cognitive and clinical disability across MS subtypes: The role of the underlying brain damage.
    Gois LCP; Pimentel-Silva LR; Damasceno BP; Damasceno A
    Mult Scler Relat Disord; 2021 Feb; 48():102701. PubMed ID: 33477004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Event related potential and response time give evidence for a physiological reserve in cognitive functioning in relapsing-remitting multiple sclerosis.
    Sundgren M; Wahlin Å; Maurex L; Brismar T
    J Neurol Sci; 2015 Sep; 356(1-2):107-12. PubMed ID: 26117361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Neuropsychological Impairment in Relapsing Remitting Multiple Sclerosis: The Role of Clinical Measures, Treatment, and Neuropsychiatry Symptoms.
    Lozano-Soto E; Cruz-López ÁJ; Gutiérrez R; González M; Sanmartino F; Rashid-Lopez R; Espinosa-Rosso R; Forero L; González-Rosa JJ
    Arch Clin Neuropsychol; 2021 May; 36(4):475-484. PubMed ID: 33067616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different cognitive profiles of Brazilian patients with relapsing-remitting and primary progressive multiple sclerosis.
    Rodrigues DN; Paes RA; Vasconcelos CC; Landeira-Fernandez J; Alvarenga MP
    Arq Neuropsiquiatr; 2011 Aug; 69(4):590-5. PubMed ID: 21877025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study.
    Amato MP; Portaccio E; Goretti B; Zipoli V; Iudice A; Della Pina D; Malentacchi G; Sabatini S; Annunziata P; Falcini M; Mazzoni M; Mortilla M; Fonda C; De Stefano N;
    Mult Scler; 2010 Dec; 16(12):1474-82. PubMed ID: 20729256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perception of affective prosody in patients at an early stage of relapsing-remitting multiple sclerosis.
    Kraemer M; Herold M; Uekermann J; Kis B; Daum I; Wiltfang J; Berlit P; Diehl RR; Abdel-Hamid M
    J Neuropsychol; 2013 Mar; 7(1):91-106. PubMed ID: 23126275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct cognitive impairments in different disease courses of multiple sclerosis-A systematic review and meta-analysis.
    Johnen A; Landmeyer NC; Bürkner PC; Wiendl H; Meuth SG; Holling H
    Neurosci Biobehav Rev; 2017 Dec; 83():568-578. PubMed ID: 28890199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating levels of interleukin-17A, tumor necrosis factor-alpha, interleukin-18, interleukin-10, and cognitive performance of patients with relapsing-remitting multiple sclerosis.
    Trenova AG; Slavov GS; Draganova-Filipova MN; Mateva NG; Manova MG; Miteva LD; Stanilova SA
    Neurol Res; 2018 Mar; 40(3):153-159. PubMed ID: 29297273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis.
    Zhao X; Yang T; Cheng F; Yang S; Zhu W; Li S; Fan Y
    J Tradit Chin Med; 2021 Apr; 41(2):316-325. PubMed ID: 33825413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
    Sacco R; Bisecco A; Corbo D; Della Corte M; d'Ambrosio A; Docimo R; Gallo A; Esposito F; Esposito S; Cirillo M; Lavorgna L; Tedeschi G; Bonavita S
    J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive trajectories in relapsing-remitting multiple sclerosis: A longitudinal 6-year study.
    Damasceno A; Pimentel-Silva LR; Damasceno BP; Cendes F
    Mult Scler; 2020 Nov; 26(13):1740-1751. PubMed ID: 31603042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical thickness and surface area relate to specific symptoms in early relapsing-remitting multiple sclerosis.
    Nygaard GO; Walhovd KB; Sowa P; Chepkoech JL; Bjørnerud A; Due-Tønnessen P; Landrø NI; Damangir S; Spulber G; Storsve AB; Beyer MK; Fjell AM; Celius EG; Harbo HF
    Mult Scler; 2015 Apr; 21(4):402-14. PubMed ID: 25139946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological characteristics of benign multiple sclerosis patients: A two-year matched cohort study.
    Hegedüs K; Kárpáti J; Iljicsov A; Simó M
    Mult Scler Relat Disord; 2019 Oct; 35():150-155. PubMed ID: 31376686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The influence of age and illness duration on cognitive impairment in aging patients with relapsing-remitting multiple sclerosis (RR-MS)].
    Leclercq E; Cabaret M; Guilbert A; Jougleux C; Vermersch P; Moroni C
    Geriatr Psychol Neuropsychiatr Vieil; 2014 Sep; 12(3):331-8. PubMed ID: 25245320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive correlates of under-ambiguity and under-risk decision making in high-functioning patients with relapsing remitting multiple sclerosis.
    Cogo MG; Rota S; Fusco ML; Mapelli C; Ferri F; Appollonio IM; Isella V
    J Clin Exp Neuropsychol; 2014; 36(10):1066-75. PubMed ID: 25486588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis.
    Sundgren M; Maurex L; Wahlin Å; Piehl F; Brismar T
    Arch Clin Neuropsychol; 2013 Mar; 28(2):144-55. PubMed ID: 23291310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis.
    Planche V; Gibelin M; Cregut D; Pereira B; Clavelou P
    Eur J Neurol; 2016 Feb; 23(2):282-9. PubMed ID: 25903918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.